Simulations Plus

According to an article published by United Nations News last year, women in STEM are still not the norm. Only one in three researchers worldwide is female.

GastroPlus® Newsletter February 2024

Unlocking the Power of PBPK Modeling

If a new drug candidate behaves unexpectedly when dosed to animals or humans, it’s likely to delay or even terminate the drug’s development.

GastroPlus® Newsletter January 2024

10 Most Read Journal Articles of 2023

In our industry, new research is constantly evolving our most current knowledge—and it’s critical to stay up-to-date with the latest advancements and best practices.

GastroPlus® Newsletter December 2023

In the highly regulated world of clinical research, compliance is an ongoing concern, but can be viewed as an annoying and costly item to check off a regulatory to-do list.

Fully Power Your First-in-Human Predictions

Determining appropriate dosage for your first in human (FIH) clinical trials is critical.

GastroPlus® Newsletter November 2023

Are your clinical trials showing potential liver toxicity?

There are many different things that make a model "good."

Using ionization modeling to inform drug discovery and decision-making

GastroPlus® Newsletter October 2023

Effective de novo drug design is a long-standing but elusive goal for computational chemistry.

GastroPlus® Newsletter September 2023

Increasing the probability of success in clinical trials

GastroPlus® Newsletter August 2023